AC141272.1 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AC233755.2 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| ![](/images/21127/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21127/112740_B_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| ![](/images/31365/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/31365/67667_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ANXA2R | Annexin A2 receptor | Predicted intracellular proteins
| ![](/images/51482/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51482/121888_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP15 | Rho GTPase activating protein 15 | Predicted intracellular proteins
| ![](/images/32125/ihc_selected_60x60.jpg) | ![](/images/32125/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/32125/72684_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins Predicted intracellular proteins
| | ![](/images/61395/1419_G8_3_selected_60x60.jpg) | ![](/images/35346/147080_A_9_11_selected_60x60.jpg) | ![](/images/35346/70558_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ARL11 | ADP-ribosylation factor-like 11 | Disease related genes Predicted intracellular proteins
| ![](/images/40855/ihc_selected_60x60.jpg) | ![](/images/40855/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40855/87644_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| ![](/images/5862/ihc_selected_60x60.jpg) | | ![](/images/5862/ihc_cell_selected_60x60.jpg) | ![](/images/5862/15412_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images/51384/ihc_selected_60x60.jpg) | ![](/images/51384/1370_G5_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51384/117261_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Predicted intracellular proteins Transcription factors
| ![](/images/64962/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/64962/152378_A_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
BCAS4 | Breast carcinoma amplified sequence 4 | Disease related genes Predicted intracellular proteins
| ![](/images/38812/ihc_selected_60x60.jpg) | ![](/images/38812/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38812/89660_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | ![](/images/49117/1363_F2_2_selected_60x60.jpg) | | ![](/images/49117/110535_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68791/155286_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes Predicted intracellular proteins
| ![](/images/52984/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52984/127686_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CCL17 | Chemokine (C-C motif) ligand 17 | Predicted secreted proteins
| ![](/images/2583/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2583/6861_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5067/13768_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3740/11072_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/3883/11412_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/24353/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2418/6099_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8750/27531_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD28 | CD28 molecule | CD markers Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13055/32209_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43955/119468_A_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17520/39922_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images/45827/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45827/105628_A_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/20308/if_selected_60x60.jpg) | | ![](/images/15392/34316_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2489/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2489/6143_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/39079/134055_A_2_5_selected_60x60.jpg) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| ![](/images/9178/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25368/56075_B_1_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70502/156477_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4353/13280_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD96 | CD96 molecule | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/66754/155816_A_4_2_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66754/155817_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CETP | Cholesteryl ester transfer protein, plasma | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CHMP7 | Charged multivesicular body protein 7 | Predicted intracellular proteins
| ![](/images/36119/ihc_selected_60x60.jpg) | ![](/images/36119/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36119/79687_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC2D | C-type lectin domain family 2, member D | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/17649/ihc_selected_60x60.jpg) | ![](/images/47584/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17649/40457_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted intracellular proteins Predicted membrane proteins
| ![](/images/29432/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29432/60663_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC9A | C-type lectin domain family 9, member A | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CLECL1 | C-type lectin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CLLU1OS | Chronic lymphocytic leukemia up-regulated 1 opposite strand | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CRTAM | Cytotoxic and regulatory T cell molecule | CD markers Predicted membrane proteins
| ![](/images/54595/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54595/125656_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CTB-133G6.1 | | Predicted membrane proteins
| ![](/images/49151/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49151/127172_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |